PeptiSlim
PeptiSlim's purity-focus record is strongest in Retatrutide, GHK-Cu, and lately Tirzepatide, with recent results generally cleaner than earlier misses. Weakness is concentrated in Tesamorelin and sparse Cagrilintide, plus Semaglutide's underfill outlier; evidence is current but dispersed, with uneven batch IDs.
Vendor-published COAs, Hong Kong contacts, and a Limeiren TikTok trail point past the US storefront to a Limeiren manufacturer layer. The report also maps AU placeholder addresses, hidden payment-descriptor language, brand-lineage leads, and regulatory exposure.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including PeptiSlim rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 21 Jul 2026 | Pass | Tirzepatide PeptiSlim | lab name | View COA | |||
| 21 Jul 2026 | Pass | Tirzepatide PeptiSlim | lab name | View COA | |||
| 14 Jul 2026 | Fail | Tesamorelin PeptiSlim | lab name | View COA | |||
| 26 Jun 2026 | Pass | Tirzepatide PeptiSlim | lab name | View COA | |||
| 26 Jun 2026 | Pass | Tirzepatide PeptiSlim | lab name | View COA | |||
| 26 Jun 2026 | Pass | Tirzepatide PeptiSlim | lab name | View COA | |||
| 26 Jun 2026 | Pass | Tirzepatide PeptiSlim | lab name | View COA | |||
| 26 Jun 2026 | Pass | Tirzepatide PeptiSlim | lab name | View COA | |||
| 23 Jun 2026 | Pass | Tirzepatide PeptiSlim | lab name | View COA | |||
| 22 Jun 2026 | Pass | Tirzepatide PeptiSlim | lab name | View COA | |||
About PeptiSlim test results from Finnrick
PeptiSlim is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 71 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible PeptiSlim peptides in this dataset are Tirzepatide (29 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 71 recent tests.